22-Year-Old With Chronic Asthma Died After Inhaler Price Went From $66 to $539: Lawsuit
The parents of a 22-year-old Wisconsin man who died after an asthma attack have filed a lawsuit against Walgreens and ...
Why a common asthma drug will now carry extra safety warnings about depression
Australia's Therapeutic Goods Administration (TGA) recently issued a safety alert requiring extra warnings to be included ...
pharmaphorum1 天
Stopwatch starts on reviews of GSK's long-acting asthma drug
Depemokimab is a follow-up to GSK's Nucala (mepolizumab), a once-monthly IL-5 inhibitor approved for severe asthma, CRSwNP, ...
'Chose rent over his medicine': Parents of 22-year-old who died from asthma attack sue ...
The parents of a young Wisconsin man have sued Walgreens and pharmacy benefit manager OptumRx over their son’s death from an ...
Fierce Healthcare2 天
HCSC tightens asthma infusion coverage, providers slam decision
Blue Cross Blue Shield company Health Care Service Corporation is limiting access for in-office administration of asthma ...
Science Daily4 天
Asthma News
21, 2025 — A new study found that pregnant women are regularly excluded from clinical drug ... of these medications for maternal and child ... The Nose Knows: Nasal Swab Detects Asthma Type ...
GSK says asthma and nasal polyps therapy under EU review
GSK (GSK) stock in focus as its experimental drug depemokimab undergoes EU review for asthma and nasal polyps. Read more here ...
Ozempic, Wegovy among drugs selected for Medicare's price negotiations
The Biden administration announced Friday that Ozempic, Wegovy and 13 additional drugs will now be covered under Medicare ...